WuXi AppTec acquires UK gene therapy company Oxgene
WuXi AppTec has completed its acquisition of Oxgene, a UK contract research and development organization that designs and develops scalable gene therapy technologies.
WuXi AppTec has completed its acquisition of Oxgene, a UK contract research and development organization that designs and develops scalable gene therapy technologies.
This week France has raised the age limit for the AstraZeneca COVID-19 vaccine; but Canada, conversely, has put a 65-year-old limit into its recommendations.
The gene-editing and genome-engineering company, eGenesis, today announced the completion of a US$125m Series C financing round.
AstraZeneca, through its partnership with the Serum Institute of India, says it is the biggest initial COVID-19 vaccine supplier to COVAX.